
NASDAQ:VIE
The current stock price of VIE is 53.01 null. Today VIE is down by 0%. In the past month the price increased by 0.38%. In the past year, price increased by 35.64%.
ChartMill assigns a technical rating of 8 / 10 to VIE. When comparing the yearly performance of all stocks, VIE turns out to be only a medium performer in the overall market: it outperformed 41.15% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to VIE. VIE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months VIE reported a non-GAAP Earnings per Share(EPS) of -2.83. The EPS increased by 59.69% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1293.07% | ||
| ROA | -35.6% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.
Viela Bio Inc
1 MEDIMMUNE WAY
GAITHERSBURG MD 20878
CEO: Zhengbin (Bing) Yao
Phone: 240-780-6356
Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.
The current stock price of VIE is 53.01 null.
VIE does not pay a dividend.
VIE has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Viela Bio Inc (VIE) has a market capitalization of 2.91B null. This makes VIE a Mid Cap stock.